This Website is for Pateints only. We do not deal with Medical Institutions or Pharmaceutical Companies

Cancer Medicine :: Muir-Torre Syndrome

Muir-Torre Syndrome

What are the screening options for Muir-Torre syndrome?

Screening recommendations for Muir-Torre syndrome are similar to those for Lynch syndrome. It is important to discuss the following screening options with your doctor, as each individual is different:

General screening guidelines

Colonoscopy (the doctor inserts a long, thin, flexible tube into the anus to check for abnormalities within the colon and rectum) every one to two years, beginning between the ages of 20 to 25 (or five years younger than the earliest age at diagnosis in the family, whichever is sooner)

Periodic upper endoscopy (a thin, lighted, flexible tube with a small video camera is inserted into your mouth and down your esophagus to look for tumors or other abnormalities) to look for stomach or intestinal cancer may be done, especially if a family member has had one of these cancers

Yearly urine cytology to screen for urinary tract cancer

Dermatologic (skin) screening at least once a year, beginning in early adulthood (or five to 10 years before the earliest age at which skin problems developed in the family, whichever is sooner)

Screening for women, beginning between the ages of 25 to 30

Yearly pelvic examination

Pap test

Transvaginal ultrasound (a test where an small ultrasound probe is inserted like a speculum for a pelvic examination in order to obtain better imaging of the uterus)

Endometrial biopsy (a biopsy of the inner lining of the uterus done as a part of a pelvic examination)

CA-125 blood test (a test to detect a protein found to be elevated in the blood of some women with ovarian cancer)

Screening options may change over time as new technologies are developed and more is learned about Muir-Torre syndrome. It is important to talk with your doctor about appropriate screening tests.

Recent News and Articles Obesity primes the colon for cancer, study finds Common Respiratory Diseases Tied to Lung Cancer Risk